Pramipexole Dihydrochloride
Pharmaceutical Secondary Standard; Certified Reference Material
Manufacturer: Supelco
CAS Number: 191217-81-9
Synonym(S): Pramipexole dihydrochloride monohydrate, (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino) benzothiazole dihydrochloride
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 500 MG | PHR1598-500-MG | In Stock | ₹ 10,911.60 |
PHR1598 - 500 MG
In Stock
Quantity
1
Base Price: ₹ 10,911.60
GST (18%): ₹ 1,964.088
Total Price: ₹ 12,875.688
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to Ph. Eur. Y0001266traceable to USP 1553859
API family
pramipexole
CofA
current certificate can be downloaded
packaging
pkg of 500 mg
technique(s)
HPLC: suitablegas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Selleck Chemical LLC Pramipexole 2HCl Monohydrate 10mg 191217-81-9 | -- | ₹ 8,111.09 | |
| | Sigma Aldrich Fine Chemicals Biosciences Pramipexole dihydrochloride monohydrate European Pharmacopoeia (EP) Reference Standard | 191217-81-9 | | -- | ₹ 16,036.51 | |
| | Pramipexole Dihydrochloride Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 11,807.28 | |
| | Sigma Aldrich Fine Chemicals Biosciences Pramipexole dihydrochloride monohydrate United States Pharmacopeia (USP) Reference Standard | 191217-81-9 | 200MG | -- | ₹ 45,791.71 | |
| | Pramipexole dihydrochloride monohydrate | -- | ₹ 40,756.13 | |
| | Pramipexole dihydrochloride monohydrate | -- | ₹ 14,072.50 | |
| | 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, hydrochloride, hydrate (1:2:1), (6S)- | -- | ₹ 598.92 - ₹ 43,892.28 | |
| | Pramipexole (dihydrochloride hydrate) | -- | ₹ 4,449.12 - ₹ 11,379.48 | |
| | 191217-81-9 | Pramipexole DiHCl monohydrate | -- | ₹ 1,711.20 - ₹ 12,491.76 |
Related Products
Description
- General description: Pramipexole Dihydrochloride is a non-ergot dopamine agonist widely used for the treatment of early and advanced Parkinson′s disease (PD). It is also used to treat restless legs syndrome.[1]Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
- Application: Pramipexole Dihydrochloride may be used as a secondary pharma standard for the determination of the analyte in pharmaceutical formulations[1][2] by spectrophotometric technique.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
- Footnote: To see an example of a Certificate of Analysis for this material enter LRAA4714 in the slot below. This is an example certificate only and may not be the lot that you receive.
- Recommended products: Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P271 - P301 + P312 - P304 + P340 + P312 - P403 + P233
Hazard Classifications
Acute Tox. 4 Oral - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable